Public-health experts say that if the therapy proves safe and effective in human trials, it could reduce long-term disability and healthcare costs linked to Chikungunya, while strengthening India’s preparedness for future outbreaks.
from Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/5WyzI43
via gqrds
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment